Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Ar Asokan
Duke University, Department: Surgery
Should you be removed from our database? Contact us at [email protected]. Read more below.
StrideBio, Inc.
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Dr. Asokan has equity in StrideBio which has licensed IP used in this project. He is responsible for the oversight , experimental design, and data analysis.
Evolving High Potency AAV Vectors for Neuromuscular Genome Editing
PROJECT NARRATIVE Recombinant adeno-associated viruses (AAV) have emerged as safe and effective vectors for clinical gene therapy applications including systemic treatment of neuromuscular diseases such as Spinal Muscular Atrophy (SMA), Duchenne Muscular Dystrophy (DMD), and Giant Axonal Neuropathy (GAN) amongst others. However, genome editing in neuromuscular tissue, in particular, is challenging. The current proposal is on a comprehensive and innovative approach to evolve high potency AAV variants for systemic neuromuscular genome editing.
Filed on October 02, 2018.
Tell us what you know about Ar Asokan's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Ar Asokan filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Aravind Asokan | Univ of North Carolina Chapel Hill | Conflict of Interest | AskBio | $0 - $4,999 |
| Aravind Asokan | Univ of North Carolina Chapel Hill | Conflict of Interest | Stride Therapeutics | $0 - $4,999 |
| Aravind Asokan | Univ of North Carolina Chapel Hill | Conflict of Interest | Stride Therapeutics | Value cannot be readily determined |
| Aravind Asokan | Duke University | Conflict of Interest | StrideBio, Inc. | Value cannot be readily determined |
| Aravind Asokan | Duke University | Conflict of Interest | TorqueBio | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.